Squarepoint’s Deciphera Pharmaceuticals DCPH Stock Holding History
Bought
Maintained
Sold
Other funds holding DCPH
Squarepoint's DCPH Position: Q4 2023 in Review
Squarepoint sold out of Deciphera Pharmaceuticals (DCPH) in Q4 2023, closing a stake of 64,159 shares — an estimated $816K sold.
Squarepoint first reported a position in DCPH in Q2 2018 and held it in 16 quarters. The position peaked at $2.39M in Q1 2023. 164 funds tracked by Wall St. Rank hold DCPH as of Q4 2023.
- Squarepoint reported no remaining Deciphera Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Squarepoint sold 64,159 Deciphera Pharmaceuticals shares in Q4 2023, an estimated $816K.
- Squarepoint first reported a position in Deciphera Pharmaceuticals in Q2 2018 and held it in 16 quarters.
- Squarepoint's Deciphera Pharmaceuticals position peaked at $2.39M in Q1 2023.
- 164 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals as of Q4 2023.
Based on Squarepoint's 13F filing for Q4 2023, filed 14 Feb 2024.